Bøker av Forum on Neuroscience and Nervous System Disorders

Presents the summary of a workshop convened by the IOM Forum on Neuroscience and Nervous System Disorders to examine opportunities to accelerate early phases of drug development for nervous system drug discovery.

An international workshop was convened in 2009, by the S Institute of Medicine (IOM) Forum on Neuroscience and Nervous Systems Disorders and the Uganda National Academy of Sciences (UNAS) Forum on Health and Nutrition. This title outlines the presentations and discussions by panelists and participants of the plenary sessions of the workshop.

Presents the summary of a workshop hosted by the Institute of Medicine\'s (IOM\'s) Forum on Neuroscience and Nervous System Disorders in Spring 2012 to explore commonalities across neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD).

Sharing Clinical Research Data: Workshop Summary

Identifies methods to facilitate development of corresponding animal and clinical endpoints, indentifies methods that would maximize bidirectional translation between basic and clinical research and determines the next steps that can be critical for improvement of the development and testing of animal models of disorders of the nervous system.

"Biological differences between the sexes influence not only individual health but also public health, biomedical research, and health care. The Institute of Medicine held a workshop March 8-9, 2010, to discuss sex differences and their implications for translational neuroscience research, which bridges the gap between scientific discovery and application...."--

"In August 2009 the Uganda National Academy of Sciences Forum on Health and Nutrition and the U.S. Institute of Medicine's Forum on Neuroscience and Neurological Disorders (Box I-1) jointly hosted a workshop in Kampala, Uganda, titled Quality of Care Issues for Mental Health and Neurological Disorders in Sub-Saharan Africa."--P. 3

Discusses the practical arenas in neuroscience in which biomarkers have the greatest impact. This title identifies biomarker targets that are being pursued and that could have the near-term impact on the rate at which fresh treatments are brought forward for psychiatric and neurological disorders.